Q4 2013 · —
Revenue$220.77M$220.77M +3.0% vs Q4 2012+3.5% vs Q3 2013
Net Income$13.77M$13.77M +7.7% vs Q4 2012N/M vs Q3 2013
EPS Diluted$0.45$0.45 −2.2% vs Q4 2012N/M vs Q3 2013
Gross Profit$136,932,000+3.3%
Operating Incomederived$63,148,000+240.3%
Operating Cash Flowderived$11,696,000N/M
Free Cash Flowderived$7,117,000N/M
Margins · derived
Gross margin62.0%+0.2 pt vs Q4 2012
Operating margin28.6%+19.9 pt vs Q4 2012
Net margin6.2%+0.3 pt vs Q4 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|
| Revenue | $220.77M | $214.43M | $203.52M | $194.13M |
| Net Income | $13.77M | $12.79M | $4.56M | $18.81M |
| EPS Diluted | $0.45 | $0.46 | $0.16 | $0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR